Rothschild Capital Partners adds UnitedHealth Group Inc (UNH) to its portfolio

UnitedHealth Group Inc (UNH) : Rothschild Capital Partners added new position in UnitedHealth Group Inc during the most recent quarter end. The investment management firm now holds 17,183 shares of UnitedHealth Group Inc which is valued at $2,434,487 , the company said in a statement filed on Jul 26, 2016 with the SEC.UnitedHealth Group Inc makes up approximately 1.25% of Rothschild Capital Partners’s portfolio.

Other Hedge Funds, Including , Artemis Investment Management Llp added UNH to its portfolio by purchasing 70,100 company shares during the most recent quarter which is valued at $9,931,768. UnitedHealth Group Inc makes up approx 0.26% of Artemis Investment Management Llp’s portfolio.Newsquare Capital reduced its stake in UNH by selling 84 shares or 9.09% in the most recent quarter. The Hedge Fund company now holds 840 shares of UNH which is valued at $119,011. UnitedHealth Group Inc makes up approx 0.03% of Newsquare Capital’s portfolio.Premier Asset Managment reduced its stake in UNH by selling 1,650 shares or 2.63% in the most recent quarter. The Hedge Fund company now holds 61,020 shares of UNH which is valued at $8,727,080. UnitedHealth Group Inc makes up approx 2.13% of Premier Asset Managment’s portfolio.Cedar Hill Associates reduced its stake in UNH by selling 2,005 shares or 1.68% in the most recent quarter. The Hedge Fund company now holds 117,058 shares of UNH which is valued at $16,475,914. UnitedHealth Group Inc makes up approx 2.75% of Cedar Hill Associates’s portfolio.

UnitedHealth Group Inc opened for trading at $141.85 and hit $143.895 on the upside on Friday, eventually ending the session at $143.2, with a gain of 0.31% or 0.44 points. The heightened volatility saw the trading volume jump to 32,69,716 shares. Company has a market cap of $136,155 M.

On the company’s financial health, UnitedHealth Group Inc reported $1.96 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.89. The company had revenue of $46485.00 million for the quarter, compared to analysts expectations of $45039.08 million. The company’s revenue was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS.

Many Wall Street Analysts have commented on UnitedHealth Group Inc. UnitedHealth Group Inc was Upgraded by Argus to ” Buy” on Jul 22, 2016. Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 165 from a previous price target of $157 .Company shares were Reiterated by Mizuho on Jul 19, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $156 .

UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.

Leave a Reply

UnitedHealth Group Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on UnitedHealth Group Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.